BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 31257340)

  • 1. Relation of Systolic Blood Pressure on the Following Day with Post-Discharge Mortality in Hospitalized Heart Failure Patients with Preserved Ejection Fraction.
    Sato Y; Yoshihisa A; Oikawa M; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T
    Int Heart J; 2019 Jul; 60(4):876-885. PubMed ID: 31257340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic impact of chronic obstructive pulmonary disease on adverse prognosis in hospitalized heart failure patients with preserved ejection fraction - A report from the JASPER registry.
    Sato Y; Yoshihisa A; Oikawa M; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T
    J Cardiol; 2019 Jun; 73(6):459-465. PubMed ID: 30718015
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic Significance of Low Systolic Blood Pressure at Discharge in Patients with Heart Failure and Preserved Ejection Fraction.
    Li S; Li X
    High Blood Press Cardiovasc Prev; 2017 Dec; 24(4):405-412. PubMed ID: 28725953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyponatremia at discharge is associated with adverse prognosis in acute heart failure syndromes with preserved ejection fraction: a report from the JASPER registry.
    Sato Y; Yoshihisa A; Oikawa M; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T
    Eur Heart J Acute Cardiovasc Care; 2019 Oct; 8(7):623-633. PubMed ID: 30667275
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic impact of moderate mitral regurgitation on hospitalized heart failure patients with preserved ejection fraction: A report from the JASPER registry.
    Oikawa M; Yoshihisa A; Sato Y; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T
    Heart Vessels; 2020 Aug; 35(8):1087-1094. PubMed ID: 32193620
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial.
    Ambrosy AP; Vaduganathan M; Mentz RJ; Greene SJ; Subačius H; Konstam MA; Maggioni AP; Swedberg K; Gheorghiade M
    Am Heart J; 2013 Feb; 165(2):216-25. PubMed ID: 23351825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rate pressure product and the components of heart rate and systolic blood pressure in hospitalized heart failure patients with preserved ejection fraction: Insights from ASCEND-HF.
    Verma AK; Sun JL; Hernandez A; Teerlink JR; Schulte PJ; Ezekowitz J; Voors A; Starling R; Armstrong P; O'Conner CM; Mentz RJ
    Clin Cardiol; 2018 Jul; 41(7):945-952. PubMed ID: 29781109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in blood pressure riser pattern in patients with acute heart failure with reduced mid-range and preserved ejection fraction.
    Ueda T; Kawakami R; Nakada Y; Nakano T; Nakagawa H; Matsui M; Nishida T; Onoue K; Soeda T; Okayama S; Watanabe M; Okura H; Saito Y
    ESC Heart Fail; 2019 Oct; 6(5):1057-1067. PubMed ID: 31325235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Geriatric nutritional risk index predicts all-cause deaths in heart failure with preserved ejection fraction.
    Nishi I; Seo Y; Hamada-Harimura Y; Yamamoto M; Ishizu T; Sugano A; Sato K; Sai S; Obara K; Suzuki S; Koike A; Aonuma K; Ieda M;
    ESC Heart Fail; 2019 Apr; 6(2):396-405. PubMed ID: 30706996
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic Impact of Worsening Renal Function in Hospitalized Heart Failure Patients With Preserved Ejection Fraction: A Report From the JASPER Registry.
    Sato Y; Yoshihisa A; Oikawa M; Nagai T; Yoshikawa T; Saito Y; Yamamoto K; Takeishi Y; Anzai T
    J Card Fail; 2019 Aug; 25(8):631-642. PubMed ID: 31004785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.
    Lupón J; Díez-López C; de Antonio M; Domingo M; Zamora E; Moliner P; González B; Santesmases J; Troya MI; Bayés-Genís A
    Eur J Heart Fail; 2017 Dec; 19(12):1615-1623. PubMed ID: 28387002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics, Management, and Outcomes of Japanese Patients Hospitalized for Heart Failure With Preserved Ejection Fraction - A Report From the Japanese Heart Failure Syndrome With Preserved Ejection Fraction (JASPER) Registry.
    Nagai T; Yoshikawa T; Saito Y; Takeishi Y; Yamamoto K; Ogawa H; Anzai T;
    Circ J; 2018 May; 82(6):1534-1545. PubMed ID: 29576598
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between systolic blood pressure and preserved or reduced ejection fraction at admission in patients hospitalized for acute heart failure syndromes.
    Kajimoto K; Sato N; Sakata Y; Takano T;
    Int J Cardiol; 2013 Oct; 168(5):4790-5. PubMed ID: 23962780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic impact of systolic blood pressure in acute heart failure with preserved ejection fraction in older patients.
    Putot S; Hacquin A; Manckoundia P; Putot A
    ESC Heart Fail; 2021 Dec; 8(6):5493-5500. PubMed ID: 34664426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective blood hemoglobin level to predict prognosis in heart failure with preserved left ventricular ejection fraction: results of the Japanese heart failure syndrome with preserved ejection fraction registry.
    Okuno K; Naito Y; Asakura M; Sugahara M; Ando T; Yasumura S; Nagai T; Saito Y; Yoshikawa T; Masuyama T; Anzai T
    Heart Vessels; 2019 Jul; 34(7):1168-1177. PubMed ID: 30675647
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).
    Carson PE; Anand IS; Win S; Rector T; Haass M; Lopez-Sendon J; Miller A; Teerlink JR; White M; McKelvie RS; Komajda M; Zile MR; McMurray JJ; Massie B
    JACC Heart Fail; 2015 Jun; 3(6):429-441. PubMed ID: 25982110
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systolic Blood Pressure and Outcomes in Patients With Heart Failure With Preserved Ejection Fraction.
    Tsimploulis A; Lam PH; Arundel C; Singh SN; Morgan CJ; Faselis C; Deedwania P; Butler J; Aronow WS; Yancy CW; Fonarow GC; Ahmed A
    JAMA Cardiol; 2018 Apr; 3(4):288-297. PubMed ID: 29450487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of admission and discharge anemia status with outcomes in patients hospitalized for acute decompensated heart failure: Differences between patients with preserved and reduced ejection fraction.
    Kajimoto K; Minami Y; Otsubo S; Sato N
    Eur Heart J Acute Cardiovasc Care; 2019 Oct; 8(7):606-614. PubMed ID: 28879773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Right ventricular dysfunction in left-sided heart failure with preserved versus reduced ejection fraction.
    Bosch L; Lam CSP; Gong L; Chan SP; Sim D; Yeo D; Jaufeerally F; Leong KTG; Ong HY; Ng TP; Richards AM; Arslan F; Ling LH
    Eur J Heart Fail; 2017 Dec; 19(12):1664-1671. PubMed ID: 28597497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Prognostic Significance of Admission Tricuspid Regurgitation Pressure Gradient in Hospitalized Patients With Heart Failure With Preserved Ejection Fraction: A Report From the Japanese Real-World Multicenter Registry.
    Omote K; Nagai T; Kamiya K; Aikawa T; Tsujinaga S; Kato Y; Komoriyama H; Iwano H; Yamamoto K; Yoshikawa T; Saito Y; Anzai T
    J Card Fail; 2019 Dec; 25(12):978-985. PubMed ID: 31344403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.